|
CAPN7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.318710E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.504600E-03 |
| Normal-vs-Stage2 |
1.403390E-01 |
| Normal-vs-Stage3 |
7.140000E-03 |
| Normal-vs-Stage4 |
1.1159999999677E-06 |
| Stage1-vs-Stage2 |
9.747800E-01 |
| Stage1-vs-Stage3 |
3.553400E-01 |
| Stage1-vs-Stage4 |
7.724300E-03 |
| Stage2-vs-Stage3 |
5.136400E-01 |
| Stage2-vs-Stage4 |
5.208000E-02 |
| Stage3-vs-Stage4 |
2.156000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.342430E-03 |
| Normal-vs-AfricanAmerican |
3.880000E-02 |
| Normal-vs-Asian |
2.940400E-03 |
| Caucasian-vs-AfricanAmerican |
8.138400E-01 |
| Caucasian-vs-Asian |
4.017800E-01 |
| AfricanAmerican-vs-Asian |
3.660600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.221030E-04 |
| Normal-vs-Female |
5.068600E-01 |
| Male-vs-Female |
3.426500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.436660E-03 |
| Normal-vs-Extreme_Weight |
1.643720E-04 |
| Normal-vs-Obese |
7.370400E-02 |
| Normal-vs-Extreme_Obese |
2.164000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.947400E-01 |
| Normal_Weight-vs-Obese |
1.280440E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.235800E-01 |
| Extreme_Weight-vs-Obese |
1.075760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.695000E-01 |
| Obese-vs-Extreme_Obese |
6.891400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.772840E-01 |
| Normal-vs-Age(41-60Yrs) |
4.245900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.795800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.520300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.790800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.429800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.548600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.015000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.708800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.085400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.270000E-02 |
| Normal-VS-Type2 PRCC |
2.25539999999524E-05 |
| Normal-VS-KIRP CIMP |
3.828800E-01 |
| Normal-VS-Unclassified PRCC |
4.112400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.644900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.716000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.528000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.352200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.658100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.626800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.79819999960252E-07 |
| Normal-vs-N1 |
1.253810E-02 |
| Normal-vs-N2 |
2.039000E-04 |
| N0-vs-N1 |
3.383200E-01 |
| N0-vs-N2 |
3.766800E-01 |
| N1-vs-N2 |
2.464200E-01 |
|
|
